- Home
- OBIO vs GENC Comparison
OBIO vs GENC Comparison
Compare OBIO & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- GENC
- Stock Information
- Founded
- OBIO 2017
- GENC 1894
- Country
- OBIO United States
- GENC United States
- Employees
- OBIO N/A
- GENC N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- GENC Construction/Ag Equipment/Trucks
- Sector
- OBIO Health Care
- GENC Industrials
- Exchange
- OBIO Nasdaq
- GENC Nasdaq
- Market Cap
- OBIO 205.0M
- GENC 283.7M
- IPO Year
- OBIO N/A
- GENC N/A
- Fundamental
- Price
- OBIO $5.83
- GENC $20.20
- Analyst Decision
- OBIO Strong Buy
- GENC
- Analyst Count
- OBIO 4
- GENC 0
- Target Price
- OBIO $15.75
- GENC N/A
- AVG Volume (30 Days)
- OBIO 44.2K
- GENC 18.8K
- Earning Date
- OBIO 11-11-2024
- GENC 12-11-2024
- Dividend Yield
- OBIO N/A
- GENC N/A
- EPS Growth
- OBIO N/A
- GENC 35.02
- EPS
- OBIO N/A
- GENC 1.11
- Revenue
- OBIO $2,079,000.00
- GENC $113,116,000.00
- Revenue This Year
- OBIO $7.68
- GENC N/A
- Revenue Next Year
- OBIO $110.40
- GENC N/A
- P/E Ratio
- OBIO N/A
- GENC $18.19
- Revenue Growth
- OBIO N/A
- GENC 5.44
- 52 Week Low
- OBIO $4.22
- GENC $13.63
- 52 Week High
- OBIO $11.69
- GENC $24.88
- Technical
- Relative Strength Index (RSI)
- OBIO 60.54
- GENC 45.28
- Support Level
- OBIO $5.20
- GENC $19.87
- Resistance Level
- OBIO $5.99
- GENC $21.42
- Average True Range (ATR)
- OBIO 0.38
- GENC 0.56
- MACD
- OBIO 0.12
- GENC -0.05
- Stochastic Oscillator
- OBIO 87.20
- GENC 11.11
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.